Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-10-17
|
pubmed:abstractText |
This study investigates whether different endogeneous vasoconstrictors exert synergistic effects in isolated human cerebral arteries, because potentiation of contractile effects may play a role in the pathogenesis of cerebral vasospasm. Isolated human pial arteries obtained from macroscopically intact tissue during brain tumour operations were mounted onto a wire myograph. Concentration-response curves of 5-hydroxytryptamine (5-HT) were constructed in the absence and presence of threshold concentrations of the thromboxane A2 (TXA)-analog U46619, and endothelin-1 (ET-1). Threshold concentrations of U46619 markedly enhanced the maximum contractile effect of 5-HT. The response to 5-HT remained markedly increased even after washout of U46619. Threshold concentrations of ET-1 increased the maximum response to 5-HT, and markedly shifted the dose-response curve to the left. Even after washout of ET-1, the dose-response curve of 5-HT remained shifted to the left. The increase of the contractile effect of 5-HT in the presence of U46619 did not correlate with the relaxant action of the endothelium-dependent vasodilator carbachol. Thus, synergism between contractile substances such as 5-HT, U46619, or ET-1 is seen in human cerebral arteries, and responses to 5-HT are potentiated even after washout of ET-1 and U46619. The potentiation does not depend on the endothelial function. We conclude that synergistic responses between endogeneous vasoconstrictors such as 5-HT, TXA and ET-1 may be involved in the pathogenesis of cerebral vasospasm after subarachnoid haemorrhage.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/15-Hydroxy-11 alpha,9...,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin Endoperoxides...,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane A2,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-6268
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
574-81; discussion 581-2
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:9248594-15-Hydroxy-11 alpha,9...,
pubmed-meshheading:9248594-Cerebral Arteries,
pubmed-meshheading:9248594-Dose-Response Relationship, Drug,
pubmed-meshheading:9248594-Endothelin-1,
pubmed-meshheading:9248594-Humans,
pubmed-meshheading:9248594-Prostaglandin Endoperoxides, Synthetic,
pubmed-meshheading:9248594-Serotonin,
pubmed-meshheading:9248594-Thromboxane A2,
pubmed-meshheading:9248594-Vasoconstrictor Agents
|
pubmed:year |
1997
|
pubmed:articleTitle |
Interactions between vasoconstrictors in isolated human cerebral arteries.
|
pubmed:affiliation |
Department of Neurosurgery, University of Kiel, Federal Republic of Germany.
|
pubmed:publicationType |
Journal Article
|